Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lina Anderhalten"'
Autor:
Jelle Praet, Lina Anderhalten, Giancarlo Comi, Dana Horakova, Tjalf Ziemssen, Patrick Vermersch, Carsten Lukas, Koen van Leemput, Marjan Steppe, Cristina Aguilera, Ella Maria Kadas, Alexis Bertrand, Jean van Rampelbergh, Erik de Boer, Vera Zingler, Dirk Smeets, Annemie Ribbens, Friedemann Paul
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Multiple sclerosis (MS) is a devastating immune-mediated disorder of the central nervous system resulting in progressive disability accumulation. As there is no cure available yet for MS, the primary therapeutic objective is to reduce relapses and to
Externí odkaz:
https://doaj.org/article/80b9b6d1dce24d1e8a507b6f0114ba9f
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 1, p 261 (2023)
In multiple sclerosis (MS), mitochondrial alterations appear to contribute to disease progression. The sphingosine-1-phosphate receptor modulator siponimod is approved for treating secondary progressive MS. Its preceding compound fingolimod was shown
Externí odkaz:
https://doaj.org/article/6ef77c33ebf644e1aca4ba6b729bbbca
Autor:
Lina Anderhalten, Rafaela V. Silva, Anna Morr, Shuangqing Wang, Alina Smorodchenko, Jessica Saatz, Heike Traub, Susanne Mueller, Philipp Boehm-Sturm, Yasmina Rodriguez-Sillke, Désirée Kunkel, Julia Hahndorf, Friedemann Paul, Matthias Taupitz, Ingolf Sack, Carmen Infante-Duarte
Publikováno v:
Investigative Radiology. 57:677-688
OBJECTIVES: Using a murine model of multiple sclerosis, we previously showed that repeated administration of gadopentetate dimeglumine led to retention of gadolinium (Gd) within cerebellar structures and that this process was enhanced with inflammati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32cb8faadf91463acc669d338c477377
https://doi.org/10.1097/rli.0000000000000884
https://doi.org/10.1097/rli.0000000000000884